反应 #657344

ord-da75f2a1155842b28855126852ef5dcf

溶剂

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他at RT
  2. 2
    温度before being cooled down
  3. 3
    其他quenched with 1N HCl (136 mL)
  4. 4
    其他THF was removed under reduced pressure
  5. 5
    萃取the aqueous layer was extracted with DCM
  6. 6
    干燥The combined organic layers were dried over Na2SO4
  7. 7
    过滤filtered
  8. 8
    浓缩concentrated under reduced pressure
  9. 9
    其他The crude solid was recrystallised in CH3CN

实验过程

To a solution of methyl[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetate (for a preparation see Intermediate 2) (28 g, 68 mmol) in THF (450 mL) at RT was added 1N NaOH (136 mL, 136 mmol). The reaction mixture was stirred at this temperature for 5 h before being cooled down and quenched with 1N HCl (136 mL). THF was removed under reduced pressure and the aqueous layer was extracted with DCM. The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude solid was recrystallised in CH3CN to give the title compound (23.9 g, 89% yield) as a pale yellow powder. 1H NMR (300 MHz, CDCl3) δ7.55-7.48 (m, 2H), 7.41 (d, J=8.9 Hz, 1H), 7.38-7.31 (m, 2H), 7.22 (dd, J=2.9 and 8.9 Hz, 1H), 6.90 (d, J=2.9 Hz, 1H), 4.59 (dd, J=6.9 and 6.9 Hz, 1H), 3.81 (s, 3H), 3.70 (dd, J=6.9 and 25.7 Hz, 1H), 3.61 (dd, J=6.9 and 25.7 Hz, 1H), 2.63 (s, 3H). LC/MS: m/z 397 [M(35Cl)+H]+, Rt 2.11 min.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US09023842B2uspto-grants-2015_05